Anavex Life Sciences Corp (AVXL)

[TempePhil]

Investor et al, all well and good. But why did Ana wait until the last 3 months, when we are ~80% enrolled, to finally open 66% MORE trial sites, with more on the way??

It appears that Ana could have had these sites up and running earlier, and finished up enrolling sooner, so Ana could have met the scheduled trial end with the 450 or more patients.

Instead, Ana chose to add all these sites near the end of enrollment, to enroll 450 (+++200??) patients and stretch out the trial completion from early next year to mid next year. Argghh

Agreed, more patients equals more statistical resolution, but if the FDA was good with 450, that should have been the goal. Or what changed??

Am I the only one unhappy about this? Seems like I have seen this before.